Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes.

[1]  L. Álvarez,et al.  Improving the in vitro dissolution rate and pharmacokinetic performance of fenbendazole in sheep using drug nanocrystals. , 2021, Research in veterinary science.

[2]  M. Kogan,et al.  Nanocrystal-based 3D-printed tablets: Semi-solid extrusion using Melting solidification printing process (MESO-PP) for Oral Administration of poorly soluble drugs. , 2021, International journal of pharmaceutics.

[3]  Xing Tang,et al.  Rod-shaped nintedanib nanocrystals improved oral bioavailability through multiple intestinal absorption pathways. , 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  Sumarheni,et al.  Albendazole Nanocrystal-Based Dissolving Microneedles with Improved Pharmacokinetic Performance for Enhanced Treatment of Cystic Echinococcosis. , 2021, ACS applied materials & interfaces.

[5]  A. Rashad,et al.  Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19 , 2021, International journal of nanomedicine.

[6]  Jie Zhuang,et al.  Improving stability and oral bioavailability of hydroxycamptothecin via nanocrystals in microparticles (NCs/MPs) technology. , 2021, International journal of pharmaceutics.

[7]  Alejandro J. Paredes,et al.  Microarray patches: breaking down the barriers to contraceptive care and HIV prevention for women across the globe. , 2021, Advanced drug delivery reviews.

[8]  I. Pepić,et al.  Efficacy and Safety of Azelaic Acid Nanocrystal-Loaded In Situ Hydrogel in the Treatment of Acne Vulgaris , 2021, Pharmaceutics.

[9]  C. Rapôso,et al.  Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Hetal P. Patel,et al.  Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies. , 2021, International journal of pharmaceutics.

[11]  Yunzhi Wang,et al.  FRET imaging revealed that nanocrystals enhanced drug oral absorption by dissolution rather than endocytosis: A case study of coumarin 6. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Weifeng Zhu,et al.  The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin , 2021, Acta pharmaceutica Sinica. B.

[13]  Maelíosa T. C. McCrudden,et al.  Enhancement strategies for transdermal drug delivery systems: current trends and applications , 2021, Drug Delivery and Translational Research.

[14]  Alejandro J. Paredes,et al.  Microneedle array systems for long-acting drug delivery. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  J. Xie,et al.  Nose-to-brain delivery of drug nanocrystals by using Ca2+ responsive deacetylated gellan gum based in situ-nanogel. , 2020, International journal of pharmaceutics.

[16]  A. Fadda,et al.  Nanosuspensions and Microneedles Roller as a Combined Approach to Enhance Diclofenac Topical Bioavailability , 2020, Pharmaceutics.

[17]  J. Lademann,et al.  Investigation of transfollicular caffeine penetration using microdialysis on ex vivo porcine ear skin. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  S. R. Pinnapireddy,et al.  Hair follicle targeting with curcumin nanocrystals: Influence of the formulation properties on the penetration efficacy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[19]  A. Chettupalli,et al.  Nanocrystals: Characterization Overview, Applications in Drug Delivery, and Their Toxicity Concerns , 2020, Journal of Pharmaceutical Innovation.

[20]  Alejandro J. Paredes,et al.  Microarray Patches: Poking a Hole in the Challenges Faced When Delivering Poorly Soluble Drugs , 2020, Advanced Functional Materials.

[21]  R. Faccio,et al.  Nanocrystals of Novel Valerolactam-Fenbendazole Hybrid with Improved in vitro Dissolution Performance , 2020, AAPS PharmSciTech.

[22]  H. McCarthy,et al.  Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  Alejandro J. Paredes,et al.  Dissolving Microneedle-Mediated Dermal Delivery of Itraconazole Nanocrystals for Improved Treatment of Cutaneous Candidiasis. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  A. Bansal,et al.  Novel nanocrystal-based formulations of apremilast for improved topical delivery , 2020, Drug Delivery and Translational Research.

[25]  A. Bansal,et al.  Formulation Aspects of Intravenous nanosuspensions. , 2020, International journal of pharmaceutics.

[26]  C. Lanusse,et al.  Ricobendazole nanocrystals obtained by media milling and spray drying: pharmacokinetic comparison with the micronized form of the drug. , 2020, International journal of pharmaceutics.

[27]  Anil B. Jindal,et al.  Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[28]  R. Haag,et al.  Nanocrystals for Improved Drug Delivery of Dexamethasone in Skin Investigated by EPR Spectroscopy , 2020, Pharmaceutics.

[29]  R. S. Abdel-Rashid,et al.  Glibenclamide nanosuspension inhaler: development, in vitro and in vivo assessment , 2020, Drug development and industrial pharmacy.

[30]  D. Jans,et al.  The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro , 2020, Antiviral Research.

[31]  Yi Jin,et al.  Mechanisms for oral absorption enhancement of drugs by nanocrystals , 2020 .

[32]  Amany M Gad,et al.  Nanocrystals of Fusidic Acid for Dual Enhancement of Dermal Delivery and Antibacterial Activity: In Vitro, Ex Vivo and In Vivo Evaluation , 2020, Pharmaceutics.

[33]  R. Ambrus,et al.  Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation. , 2020, International journal of pharmaceutics.

[34]  Pharmacokinetics , 2020, Fundamentals of Analytical Toxicology.

[35]  Qi Wang,et al.  Intranasal delivery of paeoniflorin nanocrystals for brain targeting , 2019, Asian journal of pharmaceutical sciences.

[36]  Mo Li,et al.  Impacts of particle shapes on the oral delivery of drug nanocrystals: Mucus permeation, transepithelial transport and bioavailability. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Y. Chau,et al.  Intravitreal nanoparticles for retinal delivery. , 2019, Drug discovery today.

[38]  Eneko Larrañeta,et al.  Nanosuspension-Based Dissolving Microneedle Arrays for Intradermal Delivery of Curcumin , 2019, Pharmaceutics.

[39]  H. Gendelman,et al.  The Promise of Long-Acting Antiretroviral Therapies: From Need to Manufacture. , 2019, Trends in microbiology.

[40]  U. M. Güven,et al.  Olopatadine hydrochloride loaded Kollidon® SR nanoparticles for ocular delivery: Nanosuspension formulation and in vitro–in vivo evaluation , 2019, Journal of Drug Delivery Science and Technology.

[41]  V. Brar,et al.  Therapeutic implications of nanomedicine for ocular drug delivery. , 2019, Drug discovery today.

[42]  Shashank Soni,et al.  Preparation of luliconazole nanocrystals loaded hydrogel for improvement of dissolution and antifungal activity , 2019, Heliyon.

[43]  Haiyan Hu,et al.  Drug nanocrystals: Fabrication methods and promising therapeutic applications. , 2019, International journal of pharmaceutics.

[44]  M. M. Pandey,et al.  Microneedles: A smart approach and increasing potential for transdermal drug delivery system. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[45]  Jianping Liu,et al.  Pramipexole nanocrystals for transdermal permeation: Characterization and its enhancement micro‐mechanism , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  M. Boffito,et al.  Rilpivirine long-acting for the prevention and treatment of HIV infection , 2018, Current opinion in HIV and AIDS.

[47]  A. Collier,et al.  Long-Acting Profile of 4 Drugs in 1 Anti-HIV Nanosuspension in Nonhuman Primates for 5 Weeks After a Single Subcutaneous Injection. , 2018, Journal of pharmaceutical sciences.

[48]  Eneko Larrañeta,et al.  Novel nanosuspension‐based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug , 2018, Journal of interdisciplinary nanomedicine.

[49]  Hélder A. Santos,et al.  Production of pure drug nanocrystals and nano co‐crystals by confinement methods☆ , 2018, Advanced drug delivery reviews.

[50]  Lin Sun,et al.  Recent Developments in Ophthalmic Drug Delivery Systems for Therapy of Both Anterior and Posterior Segment Diseases , 2018 .

[51]  A. Collier,et al.  Mechanism‐based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long‐acting anti‐HIV drug combination nanoparticle formulation , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[52]  N. Nagai,et al.  Enhanced percutaneous absorption of cilostazol nanocrystals using aqueous gel patch systems and clarification of the absorption mechanism. , 2018, Experimental and therapeutic medicine.

[53]  M. Herranz-López,et al.  Nutraceuticals for Skin Care: A Comprehensive Review of Human Clinical Studies , 2018, Nutrients.

[54]  Dennis Douroumis,et al.  Pharmaceutical nanocrystals: production by wet milling and applications. , 2018, Drug discovery today.

[55]  S. Palma,et al.  Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice. , 2018, Veterinary parasitology.

[56]  C. Lanusse,et al.  Albendazole nanocrystals with improved pharmacokinetic performance in mice. , 2018, Therapeutic delivery.

[57]  C. Lanusse,et al.  A nanocrystal‐based formulation improves the pharmacokinetic performance and therapeutic response of albendazole in dogs , 2018, The Journal of pharmacy and pharmacology.

[58]  V. Karri,et al.  Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting , 2017, Artificial cells, nanomedicine, and biotechnology.

[59]  Linfeng Wu,et al.  Nanoparticles for drug delivery to the anterior segment of the eye. , 2017, Advanced drug delivery reviews.

[60]  E. Fröhlich,et al.  Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[61]  Ryan F. Donnelly,et al.  Novel bilayer dissolving microneedle arrays with concentrated PLGA nano‐microparticles for targeted intradermal delivery: Proof of concept , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[62]  Di Huang,et al.  Overcoming ocular drug delivery barriers through the use of physical forces , 2017, Advanced drug delivery reviews.

[63]  Lulu Wang,et al.  Safety of nanosuspensions in drug delivery. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[64]  F. Rinaldi,et al.  Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting , 2017, Drug design, development and therapy.

[65]  K. Jaganathan,et al.  Nasal Vaccine Delivery , 2016, Micro and Nanotechnology in Vaccine Development.

[66]  Alan B. Watts,et al.  Formulation and device design to increase nose to brain drug delivery , 2016 .

[67]  Ronald A Siegel,et al.  A review of intranasal formulations for the treatment of seizure emergencies. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[68]  R. Nho,et al.  Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery , 2016, Journal of clinical medicine.

[69]  J. Jeong,et al.  Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage , 2016, International journal of nanomedicine.

[70]  Meng Li,et al.  Nanomilling of Drugs for Bioavailability Enhancement: A Holistic Formulation-Process Perspective , 2016, Pharmaceutics.

[71]  T. Mehta,et al.  Nanocrystal for ocular drug delivery: hope or hype , 2016, Drug Delivery and Translational Research.

[72]  A. Mahmoud,et al.  Nano Spray Drying Technique as a Novel Approach To Formulate Stable Econazole Nitrate Nanosuspension Formulations for Ocular Use. , 2016, Molecular pharmaceutics.

[73]  S. Palma,et al.  Self-dispersible nanocrystals of albendazole produced by high pressure homogenization and spray-drying , 2016, Drug development and industrial pharmacy.

[74]  S. Piscitelli,et al.  Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans , 2016, Xenobiotica; the fate of foreign compounds in biological systems.

[75]  Ye Li,et al.  Injected nanocrystals for targeted drug delivery , 2016, Acta pharmaceutica Sinica. B.

[76]  Ryan F. Donnelly,et al.  Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum , 2015, Pharmaceutics.

[77]  Ahmed Abdelbary,et al.  Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration , 2015, International journal of nanomedicine.

[78]  D. Marcano,et al.  Dexamethasone nanowafer as an effective therapy for dry eye disease. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[79]  R. Gemeinhart,et al.  Developing nanocrystals for cancer treatment. , 2015, Nanomedicine.

[80]  R. Farid,et al.  Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain , 2015, Drug development and industrial pharmacy.

[81]  A. Samanta,et al.  Overview of milling techniques for improving the solubility of poorly water-soluble drugs , 2015 .

[82]  H. Crauwels,et al.  Formulation and pharmacology of long-acting rilpivirine , 2015, Current opinion in HIV and AIDS.

[83]  Y. Shimomura,et al.  A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure. , 2015, Experimental eye research.

[84]  A. Grzybowski,et al.  Human ocular anatomy. , 2015, Clinics in dermatology.

[85]  S. Piscitelli,et al.  Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults , 2014, Journal of acquired immune deficiency syndromes.

[86]  E. Garvey,et al.  Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection , 2014, Antimicrobial Agents and Chemotherapy.

[87]  F. Rancan,et al.  Getting under the skin: what is the potential of the transfollicular route in drug delivery? , 2014, Therapeutic delivery.

[88]  D. Stepensky,et al.  Quantitative analysis of drug delivery to the brain via nasal route. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[89]  Jürgen Lademann,et al.  Dermal nanocrystals from medium soluble actives - physical stability and stability affecting parameters. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[90]  A. Yassin,et al.  Nanostructure-based platforms-current prospective in ophthalmic drug delivery , 2014, Indian journal of ophthalmology.

[91]  P. Liu,et al.  Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo. , 2014, International journal of pharmaceutics.

[92]  Brahmeshwar Mishra,et al.  Drug nanocrystals: A way toward scale-up , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[93]  Y. Shimomura,et al.  A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. , 2014, Toxicology.

[94]  L. Rodella,et al.  The human hair: from anatomy to physiology , 2014, International journal of dermatology.

[95]  F. Rossetti,et al.  Microneedle-based drug delivery systems for transdermal route. , 2014, Current drug targets.

[96]  A. Attama,et al.  Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus , 2014, Expert opinion on drug delivery.

[97]  Maelíosa T. C. McCrudden,et al.  Microneedles for intradermal and transdermal drug delivery. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[98]  W. Spreen,et al.  Long-acting injectable antiretrovirals for HIV treatment and prevention , 2013, Current opinion in HIV and AIDS.

[99]  J. Majoral,et al.  Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview. , 2013, Advanced drug delivery reviews.

[100]  Jan P Möschwitzer,et al.  Drug nanocrystals in the commercial pharmaceutical development process. , 2013, International journal of pharmaceutics.

[101]  Paul C. Wang,et al.  Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation. , 2013, Nanoscale.

[102]  H. Chan,et al.  Pulmonary drug delivery. , 2013, Therapeutic delivery.

[103]  R. Nave,et al.  Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects , 2013, Drug delivery.

[104]  S. Lee,et al.  Bioequivalence for Locally Acting Nasal Spray and Nasal Aerosol Products: Standard Development and Generic Approval , 2013, The AAPS Journal.

[105]  H. Gendelman,et al.  Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy , 2013, Antimicrobial Agents and Chemotherapy.

[106]  P. Vavia,et al.  Nanosuspension Based In Situ Gelling Nasal Spray of Carvedilol: Development, In Vitro and In Vivo Characterization , 2013, AAPS PharmSciTech.

[107]  Anil Kumar,et al.  Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery , 2013, Expert opinion on drug delivery.

[108]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[109]  H. Chrystyn,et al.  Droplet aerodynamics, cellular uptake, and efficacy of a nebulizable corticosteroid nanosuspension are superior to a micronized dosage form , 2012, Biotechnology progress.

[110]  Lei Gao,et al.  Drug nanocrystals: In vivo performances. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[111]  Tiziana di Matteo,et al.  Hierarchical Information Clustering by Means of Topologically Embedded Graphs , 2011, PloS one.

[112]  H. D. Hwang,et al.  Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods. , 2011, Die Pharmazie.

[113]  D. Nutt,et al.  ECNP Summit on the future of CNS drug research in Europe 2011: Report prepared for ECNP by David Nutt and Guy Goodwin , 2011, European Neuropsychopharmacology.

[114]  Elaine Merisko-Liversidge,et al.  Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. , 2011, Advanced drug delivery reviews.

[115]  Rainer H Müller,et al.  State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[116]  J. Benoit,et al.  Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? , 2011, International journal of pharmaceutics.

[117]  A. Subrizi,et al.  Barrier analysis of periocular drug delivery to the posterior segment. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[118]  Ranjita Shegokar,et al.  Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. , 2010, International journal of pharmaceutics.

[119]  R. Patlolla,et al.  Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery , 2010, Molecular membrane biology.

[120]  A. Mitra,et al.  Ocular Drug Delivery , 2010, The AAPS Journal.

[121]  S. Yamashita,et al.  Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy. , 2010, Molecular pharmaceutics.

[122]  C. Baudouin,et al.  Preservatives in eyedrops: The good, the bad and the ugly , 2010, Progress in Retinal and Eye Research.

[123]  M. Samanta,et al.  Dual-Drug Delivery System Based on In Situ Gel-Forming Nanosuspension of Forskolin to Enhance Antiglaucoma Efficacy , 2010, AAPS PharmSciTech.

[124]  E. Souto,et al.  Nanomedicines for ocular NSAIDs: safety on drug delivery. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[125]  E. Cevher,et al.  Nasal Delivery of High Molecular Weight Drugs , 2009, Molecules.

[126]  Rainer H Müller,et al.  Development of an oral rutin nanocrystal formulation. , 2009, International journal of pharmaceutics.

[127]  J. Koo,et al.  Airway mucus: the good, the bad, the sticky. , 2009, Pharmacology & therapeutics.

[128]  J. Birchall,et al.  Clinical administration of microneedles: skin puncture, pain and sensation , 2009, Biomedical microdevices.

[129]  Y. Lai,et al.  Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery , 2009, Nanoscale research letters.

[130]  Ludo Froyen,et al.  Alternative matrix formers for nanosuspension solidification: Dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[131]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[132]  Po‐Chang Chiang,et al.  Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies. , 2008, Journal of pharmaceutical sciences.

[133]  Rainer H Müller,et al.  Nanocrystal technology, drug delivery and clinical applications , 2008, International journal of nanomedicine.

[134]  Joseph Wong,et al.  Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. , 2008, Advanced drug delivery reviews.

[135]  Wenting Dai,et al.  Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. , 2008, International journal of pharmaceutics.

[136]  W. Sterry,et al.  The role of hair follicles in the percutaneous absorption of caffeine. , 2008, British journal of clinical pharmacology.

[137]  Dianrui Zhang,et al.  Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system , 2008 .

[138]  J. Jonas,et al.  Short-term complications of intravitreal injections of triamcinolone and bevacizumab , 2008, Eye.

[139]  M. Ghorab,et al.  Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. , 2007, International journal of pharmaceutics.

[140]  T. Seki,et al.  Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification , 2007, The Journal of pharmacy and pharmacology.

[141]  Colin W Pouton,et al.  Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[142]  A V Rawlings,et al.  Ethnic skin types: are there differences in skin structure and function? 1 , 2006, International journal of cosmetic science.

[143]  Rainer H Müller,et al.  Spray coated pellets as carrier system for mucoadhesive drug nanocrystals. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[144]  G. Seigel,et al.  Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. , 2006, Investigative ophthalmology & visual science.

[145]  J. Lademann,et al.  Follicular targeting--a promising tool in selective dermatotherapy. , 2005, The journal of investigative dermatology. Symposium proceedings.

[146]  P. Elias.  Stratum corneum defensive functions: an integrated view. , 2005, The Journal of investigative dermatology.

[147]  S Somavarapu,et al.  Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. , 2005, Advanced drug delivery reviews.

[148]  Paul R. Lockman,et al.  Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability , 2004, Journal of drug targeting.

[149]  J E Kipp,et al.  The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. , 2004, International journal of pharmaceutics.

[150]  Barrett E. Rabinow,et al.  Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.

[151]  J. Lademann,et al.  Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.

[152]  Selcan Türker,et al.  Nasal route and drug delivery systems , 2004, Pharmacy World and Science.

[153]  A J Bron,et al.  Functional aspects of the tear film lipid layer. , 2004, Experimental eye research.

[154]  S. Mitragotri,et al.  Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.

[155]  M. Dolovich,et al.  Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. , 2003, British journal of clinical pharmacology.

[156]  Elaine Merisko-Liversidge,et al.  Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[157]  F. Simons,et al.  Comparative pharmacology of H1 antihistamines: clinical relevance. , 2002, The American journal of medicine.

[158]  Y. Kalia,et al.  Transdermal drug delivery: overcoming the skin's barrier function. , 2000, Pharmaceutical science & technology today.

[159]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[160]  M. Singh,et al.  Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. , 2000, Current medicinal chemistry.

[161]  V. Sinha,et al.  Permeation Enhancers for Transdermal Drug Delivery , 2000, Drug development and industrial pharmacy.

[162]  Böhm,et al.  Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs. , 1999, Pharmaceutical science & technology today.

[163]  G. Na,et al.  Physical Stability of Ethyl Diatrizoate Nanocrystalline Suspension in Steam Sterilization , 1999, Pharmaceutical Research.

[164]  Shulin Ding.  RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .

[165]  J. Dressman,et al.  Effect of elevated viscosity in the upper gastrointestinal tract on drug absorption in dogs. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[166]  Romeo,et al.  Effects of physicochemical properties and other factors on systemic nasal drug delivery. , 1998, Advanced drug delivery reviews.

[167]  R. Gurny,et al.  Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations. , 1997, Pharmaceutica acta Helvetiae.

[168]  A. Gatherer.  Clinical , 1997 .

[169]  J. Patton,et al.  Mechanisms of macromolecule absorption by the lungs , 1996 .

[170]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[171]  G. Liversidge,et al.  The surface modified drug nanoparticles , 1992 .

[172]  W. Whisler,et al.  Youmans' Neurological Surgery: , 1990 .

[173]  S. Walker,et al.  Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). , 1988, British journal of clinical pharmacology.

[174]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .

[175]  Therapeutics Applications of Nanosuspension in Topical/ Mucosal Drug Delivery , 2018 .

[176]  Eneko Larrañeta,et al.  Microarray patches: potentially useful delivery systems for long-acting nanosuspensions , 2017 .

[177]  Tao Yi,et al.  A new drug nanocrystal self‐stabilized Pickering emulsion for oral delivery of silybin , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[178]  A. Chauhan,et al.  Review of ophthalmic drug delivery by contact lenses , 2014 .

[179]  Y. Shimomura,et al.  Improved corneal toxicity and permeability of tranilast by the preparation of ophthalmic formulations containing its nanoparticles. , 2014, Journal of oleo science.

[180]  S. Sahoo,et al.  Nanotechnology-Based Ophthalmic Drug Delivery System , 2014 .

[181]  P. Wlaź,et al.  Inhalable highly concentrated itraconazole nanosuspension for the treatment of bronchopulmonary aspergillosis. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[182]  J. Patil,et al.  Pulmonary drug delivery strategies: A concise, systematic review , 2012, Lung India : official organ of Indian Chest Society.

[183]  Peter R. Byron,et al.  Inhaling medicines: delivering drugs to the body through the lungs , 2007, Nature Reviews Drug Discovery.

[184]  Adrian C. Williams,et al.  Penetration enhancers. , 2004, Advanced drug delivery reviews.

[185]  R. Naclerio,et al.  Antiallergic anti-inflammatory effects of H1-antihistamines in humans. , 2002, Clinical allergy and immunology.

[186]  W. Pardridge.  Why is the global CNS pharmaceutical market so under-penetrated? , 2002, Drug discovery today.

[187]  A. El‐Kattan,et al.  Enhancement of transdermal drug delivery: chemical and physical approaches. , 2000, Critical reviews in therapeutic drug carrier systems.

[188]  W. Hoefnagels,et al.  Nasal absorption of hydroxocobalamin in healthy elderly adults. , 1998, British journal of clinical pharmacology.

[189]  R. Thorne,et al.  Delivery of 125I-NGF to the Brain via the Olfactory Route , 1997 .

[190]  J. Patton,et al.  Drug delivery via the respiratory tract. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[191]  R. B. Cole.  ESSENTIALS OF RESPIRATORY DISEASE , 1972, The Ulster Medical Journal.

[192]  Alfred N. Martin.  Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences , 1969 .

[193]  S. Gizurarson.  Send Orders of Reprints at Reprints@benthamscience.org Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery , 2022 .